Stockbabie NewsFatherMarketNewsMarket Intelligence
Subscribe
MARKETS
Wire · Earnings
Earnings

Vericel Raises FY2026 Sales Guidance from $326.000M-$336.000M to $330.000M-$340.000M vs $332.199M Est

Jul 30, 2026 · 07:55 AM ET· updated 3h ago

Vericel (NASDAQ:VCEL) raises FY2026 sales outlook from $326.000 million-$336.000 million to $330.000 million-$340.000 million vs $332.199 million estimate.

Share
Why It Matters

Vericel, a medical company, said it expects to make a bit more money next year than it thought before. When a company raises its sales forecast, it usually means things are going better than expected, which can be a sign of confidence.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
VCEL48.47
+1.85 (+3.96%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.